Engineered T Cells for Type 1 Diabetes Move Closer to Clinic
For much of the last decade, Dr. David Rawlings, director of Seattle Children’s Research Institute’s Center for Immunity and Immunotherapies, has dreamed of developing a therapy for children with type 1 diabetes that doesn’t involve insulin injections but uses a person’s own immune cells to target and treat the disease.
Original Article Source Credits: Seattle Children's , https://pulse.seattlechildrens.org/
Article Written By : LINDSAY KURS
Original Article Posted on : JUNE 8, 2020
Link to Original Article: https://pulse.seattlechildrens.org/engineered-t-cells-for-type-1-diabetes-move-closer-to-clinic/